x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF
1934
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF
1934
|
Delaware
|
56-1953785
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
(I.R.S. Employer
Identification
No.)
|
|
26361
Crown Valley Parkway, Ste. 150
Mission Viejo, California
|
92691
|
|
(Address
of principal executive offices)
|
(Zip Code)
|
(Registrant’s
telephone number, including area code)
949-481-9825
|
Class
|
Outstanding
as of
August 13, 2010
|
Common
Stock, par value $.01 per share
|
56,657,177
shares
|
Exhibit
#
|
Description
|
|
31.1
|
Certification
of the Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a)
and 15d-14(a).
|
|
31.2
|
Certification
of the Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a)
and 15d-14(a).
|
|
32.1
|
Certification
by the Chief Executive Officer and Chief Financial Officer pursuant to 18
U.S.C. §1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002.
|
AEOLUS
PHARMACEUTICALS, INC.
|
||
Date:
August 27, 2010
|
By:
|
/s/
John L. McManus
|
John
L. McManus
President
and Chief Executive Officer
(Principal
Executive Officer)
Chief
Financial Officer, Treasurer and Secretary
(Principal
Financial and Accounting Officer)
|
||